These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2506523)

  • 41. Effects of SR 44866, a potassium channel opener, on action potentials of rabbit, guinea pig, and human heart fibers.
    Gautier P; Bertrand JP; Guiraudou P
    J Cardiovasc Pharmacol; 1991 May; 17(5):692-700. PubMed ID: 1713982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of cromakalim-induced relaxation of potassium precontracted rabbit, cat, and rat isolated cerebral arteries.
    Parsons AA; Ksoll E; Mackert JR; Schilling L; Wahl M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):384-92. PubMed ID: 1906583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of rabbit aortic Ca(2+)-activated K+ channels by pinacidil, cromakalim, and glibenclamide.
    Gelband GH; McCullough JR
    Am J Physiol; 1993 May; 264(5 Pt 1):C1119-27. PubMed ID: 8498475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The involvement of potassium channels in the action of ciclazindol in rat portal vein.
    Noack T; Edwards G; Deitmer P; Greengrass P; Morita T; Andersson PO; Criddle D; Wyllie MG; Weston AH
    Br J Pharmacol; 1992 May; 106(1):17-24. PubMed ID: 1504725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoxia-evoked dilatation of rabbit isolated basilar arteries is not mediated by the opening of glibenclamide-sensitive potassium channels.
    Trezise DJ; Weston AH
    Jpn J Pharmacol; 1992; 58 Suppl 2():308P. PubMed ID: 1507569
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
    Greenwood IA; Weston AH
    Br J Pharmacol; 1993 Aug; 109(4):925-32. PubMed ID: 8401946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effects of acetylcholine, nitric oxide and levcromakalim on smooth muscle membrane potential and tone in the rabbit basilar artery.
    Plane F; Garland CJ
    Br J Pharmacol; 1993 Oct; 110(2):651-6. PubMed ID: 8242238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.
    Longman SD; Clapham JC; Wilson C; Hamilton TC
    J Cardiovasc Pharmacol; 1988; 12(5):535-42. PubMed ID: 2468052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cromakalim-induced relaxation of guinea-pig isolated trachealis: antagonism by glibenclamide and by phentolamine.
    Murray MA; Boyle JP; Small RC
    Br J Pharmacol; 1989 Nov; 98(3):865-74. PubMed ID: 2511995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of potassium channel activators on isolated cerebral arteries of large and small diameter in the cat.
    Schilling L; Parsons AA; Wahl M
    J Neurosurg; 1995 Jul; 83(1):123-8. PubMed ID: 7782827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. K(+)-channel activators in vascular smooth muscle.
    Cox RH
    Prog Clin Biol Res; 1990; 334():171-85. PubMed ID: 2309006
    [No Abstract]   [Full Text] [Related]  

  • 52. ATP-sensitive potassium channels in isolated rat aorta during physiologic, hypoxic, and low-glucose conditions.
    Hüsken BC; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):130-5. PubMed ID: 9007682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
    Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the actions of acetylcholine and BRL 38227 in the guinea-pig coronary artery.
    Eckman DM; Frankovich JD; Keef KD
    Br J Pharmacol; 1992 May; 106(1):9-16. PubMed ID: 1504734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Smooth muscle K+ channel openers; their pharmacology and clinical potential.
    Weston AH
    Pflugers Arch; 1989; 414 Suppl 1():S99-105. PubMed ID: 2674897
    [No Abstract]   [Full Text] [Related]  

  • 57. Inhibition by glibenclamide of the effects of cromakalim on responses of rat vas deferens to naphazoline.
    Grana E; Barbieri A; Zonta F
    Eur J Pharmacol; 1991 Sep; 202(1):93-6. PubMed ID: 1786804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relaxant effects of cromakalim and ATP depletion in dog and rat mesenteric arteries--species differences.
    Hong KW; Rhim BY; Kim CD; Yoo SE
    Arch Int Pharmacodyn Ther; 1994; 328(1):54-66. PubMed ID: 7893191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of guinea-pig tracheal smooth muscle responsiveness by the potassium channel openers NIP-121 and cromakalim.
    Shikada K; Yamamoto A; Tanaka S
    Jpn J Pharmacol; 1992; 58 Suppl 2():334P. PubMed ID: 1507583
    [No Abstract]   [Full Text] [Related]  

  • 60. Relaxation by cromakalim and pinacidil of isolated smooth muscle cells from canine coronary artery-multiple sites of action.
    Rhim BY; Hong KW
    Arch Int Pharmacodyn Ther; 1994; 328(1):67-81. PubMed ID: 7893192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.